CR9792A - Composiciones que contienen piperacilina y tazobactam utiles para inyecciones (divisional de exp. 8035) - Google Patents

Composiciones que contienen piperacilina y tazobactam utiles para inyecciones (divisional de exp. 8035)

Info

Publication number
CR9792A
CR9792A CR9792A CR9792A CR9792A CR 9792 A CR9792 A CR 9792A CR 9792 A CR9792 A CR 9792A CR 9792 A CR9792 A CR 9792A CR 9792 A CR9792 A CR 9792A
Authority
CR
Costa Rica
Prior art keywords
piperacilin
divisional
injections
exp
compositions containing
Prior art date
Application number
CR9792A
Other languages
English (en)
Inventor
Marc Cohen Jonathan
Muzafar Shah Syed
Lutyer Ofslager Christian
Bakir Fawzi Mahdi
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32326726&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9792(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CR9792A publication Critical patent/CR9792A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se ha comprobado que un agente quelante de acido aminocaboxilico, de preferencia EDTA o una sal con el mismo compuesto, resultan utiles para inhibir la formacion de particulas en combinaciones parenterales de piperacilina , tazobactam. Asimismo, la composicion puede contener un buffer, de preferencia un citrato y un aminoglicosidode manera opcional.
CR9792A 2003-04-14 2008-03-04 Composiciones que contienen piperacilina y tazobactam utiles para inyecciones (divisional de exp. 8035) CR9792A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46280803P 2003-04-14 2003-04-14

Publications (1)

Publication Number Publication Date
CR9792A true CR9792A (es) 2008-09-23

Family

ID=32326726

Family Applications (2)

Application Number Title Priority Date Filing Date
CR8035A CR8035A (es) 2003-04-14 2005-10-07 Composiciones que contienen piperacilina y tazobactam utiles para inyecciones
CR9792A CR9792A (es) 2003-04-14 2008-03-04 Composiciones que contienen piperacilina y tazobactam utiles para inyecciones (divisional de exp. 8035)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CR8035A CR8035A (es) 2003-04-14 2005-10-07 Composiciones que contienen piperacilina y tazobactam utiles para inyecciones

Country Status (34)

Country Link
US (3) US7498312B2 (es)
EP (1) EP1468697B1 (es)
JP (1) JP4644659B2 (es)
KR (1) KR100824554B1 (es)
CN (1) CN1802179B (es)
AR (1) AR043863A1 (es)
AT (1) ATE381947T1 (es)
AU (1) AU2004229407B2 (es)
BR (1) BRPI0409450B8 (es)
CA (1) CA2464258C (es)
CH (1) CH695185A9 (es)
CL (1) CL2004000782A1 (es)
CO (1) CO5700796A2 (es)
CR (2) CR8035A (es)
CY (1) CY1108064T1 (es)
DE (1) DE602004010862T2 (es)
DK (1) DK1468697T3 (es)
EC (1) ECSP056100A (es)
ES (1) ES2298672T3 (es)
FR (1) FR2853547B1 (es)
GB (1) GB2400557B (es)
IL (1) IL171337A (es)
MX (1) MXPA05010996A (es)
MY (1) MY139099A (es)
NO (1) NO20054789L (es)
NZ (1) NZ543005A (es)
PL (1) PL1468697T3 (es)
PT (1) PT1468697E (es)
RU (2) RU2322980C2 (es)
SA (1) SA04250119B1 (es)
SI (1) SI1468697T1 (es)
TW (1) TWI308069B (es)
WO (1) WO2004091666A1 (es)
ZA (1) ZA200508315B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2510196C (en) 2002-12-20 2014-04-01 Generipharm, Inc. Intracutaneous injection
DK1468697T3 (da) * 2003-04-14 2008-04-14 Wyeth Corp Sammensætninger indeholdende piperacillin og tazobactam, der er anvendelige til injektion
EP1799209A1 (en) * 2004-10-14 2007-06-27 Wyeth Compositions containing piperacillin, tazobactam and a aminocarboxilic acid in a sodium lactate diluent
ATE476981T1 (de) * 2004-12-02 2010-08-15 Venus Remedies Ltd Zusammensetzungen zur bekämpfung von beta- lactamase-vermittelter antibiotischer resistenz mittels beta-lactamase-hemmern für injektionen
ES2284318B1 (es) * 2005-04-13 2008-11-01 Labiana Development, S.L. Procedimiento de obtencion de una mezcla en polvo de una sal sodica de piperaciclina y tazobactama, util para su administracion por via inyectable.
ITMI20051630A1 (it) * 2005-09-02 2007-03-03 Acs Dobfar Spa Formulazione farmaceutica sterile iniettabile contenente almeno due principi attivi
CN101129383B (zh) * 2006-08-25 2014-04-02 天津和美生物技术有限公司 含氨基糖苷类抗生素的抗生素复方
CN101129381B (zh) * 2006-08-25 2012-02-01 天津和美生物技术有限公司 含β-内酰胺类抗生素和离子螯合剂的抗生素复方
CN102210679B (zh) * 2006-08-25 2013-03-13 天津和美生物技术有限公司 含哌拉西林的抗生素复方
CN101129382B (zh) * 2006-08-25 2013-12-25 天津和美生物技术有限公司 含β-内酰胺类抗生素和缓冲组分的抗生素复方
CN1927201B (zh) * 2006-08-25 2011-06-01 天津和美生物技术有限公司 含哌拉西林的抗生素复方
CN102441169A (zh) * 2006-08-25 2012-05-09 天津和美生物技术有限公司 含β-内酰胺类抗生素和离子螯合剂的抗生素复方
CN101265263B (zh) * 2008-05-12 2010-06-02 海南百那医药发展有限公司 哌拉西林钠他唑巴坦钠复方注射剂的生产方法
WO2010013640A1 (ja) * 2008-07-28 2010-02-04 Yamaguchi Keizo 感染症治療効果増強剤
JP5852316B2 (ja) * 2010-03-30 2016-02-03 富山化学工業株式会社 ピペラシリン含有懸濁液の製造法
WO2012012460A1 (en) 2010-07-19 2012-01-26 Xeris Pharmaceuticals, Inc. Stable glucagon formulations for the treatment of hypoglycemia
MX375266B (es) 2010-11-25 2025-03-06 Allecra Therapeutics Gmbh Compuestos y su uso.
AU2012225268B2 (en) 2011-03-10 2016-10-20 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of peptide drugs
EA027744B1 (ru) 2011-10-31 2017-08-31 Ксерис Фармасьютикалс, Инк. Лекарственные формы для лечения сахарного диабета
KR101536885B1 (ko) 2012-03-26 2015-07-14 산텐 세이야꾸 가부시키가이샤 디쿠아포솔 함유 점안액
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
US8476425B1 (en) * 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
KR101816798B1 (ko) * 2012-10-19 2018-01-10 주식회사유한양행 피페라실린 또는 그의 염, 타조박탐 또는 그의 염 및 덱사메타손 포스페이트 또는 그의 염을 포함하는 국소투여용 약학 조성물
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
DK2893929T3 (da) 2013-03-15 2025-07-07 Merck Sharp & Dohme Llc Antibiotisk ceftolozansammensætninger
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US20150094293A1 (en) 2013-09-27 2015-04-02 Calixa Therapeutics, Inc. Solid forms of ceftolozane
RU2733405C2 (ru) 2014-02-07 2020-10-01 Экзитера Фармасьютикалз Инк. Терапевтические соединения и композиции
WO2016022831A1 (en) 2014-08-06 2016-02-11 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
WO2016056527A1 (ja) * 2014-10-08 2016-04-14 沢井製薬株式会社 凍結乾燥製剤の製造方法
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
WO2017168394A1 (en) * 2016-03-31 2017-10-05 Wockhardt Limited Antibacterial compositions
WO2018025248A1 (en) * 2016-08-05 2018-02-08 Jodas Expoim Private Limited Edta injection and process for making the same
KR20240036128A (ko) 2017-06-02 2024-03-19 엑스에리스 파머수티클스, 인크. 침전 방지 저분자 약물 제제
US11110054B2 (en) * 2018-05-09 2021-09-07 Slayback Pharma Llc Ready-to-use injectable pharmaceutical compositions comprising neostigmine and glycopyrrolate
CN112618486B (zh) * 2020-12-24 2023-07-18 浙江昂利康制药股份有限公司 一种注射用混悬油剂及其制备方法
CN113209030B (zh) * 2021-04-27 2023-04-25 海南通用康力制药有限公司 哌拉西林钠他唑巴坦钠无菌粉针剂的制备方法
WO2025253343A1 (en) * 2024-06-06 2025-12-11 Chandan Chopra AN ANTIBIOTIC COMPOSITION OF A PENICILLIN, A β-LACTAMASE INHIBITOR AND AN ION-CHELATING AGENT
CN119367287B (zh) * 2024-12-27 2025-03-28 成都硕德药业有限公司 一种重酒石酸去甲肾上腺素注射液及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4477452A (en) 1981-03-26 1984-10-16 American Cyanamid Company Composition of matter comprising a lyophilized preparation of a penicillin derivative
US4534977A (en) 1981-03-26 1985-08-13 American Cyanamid Company Composition of matter comprising a low bulk density lyophilized preparation of Sodium Piperacillin
US4562073A (en) 1982-12-24 1985-12-31 Taiho Pharmaceutical Company Limited Penicillin derivatives
US5763480A (en) * 1994-02-14 1998-06-09 The Jewish Hospital Of St. Louis Inhibitors of cell-medicated disorders
US5580856A (en) 1994-07-15 1996-12-03 Prestrelski; Steven J. Formulation of a reconstituted protein, and method and kit for the production thereof
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US6207661B1 (en) 1999-02-22 2001-03-27 Baxter International Inc. Premixed formulation of piperacillin sodium and tazobactam sodium injection
WO2003088914A2 (en) * 2002-04-18 2003-10-30 The University Of Iowa Research Foundation Methods of inhibiting and treating bacterial biofilms by metal chelators
AU2003230899A1 (en) * 2003-04-14 2004-11-26 Wyeth Holdings Corporation Compositions containing piperacillin and tazobactam useful for injection
DK1468697T3 (da) 2003-04-14 2008-04-14 Wyeth Corp Sammensætninger indeholdende piperacillin og tazobactam, der er anvendelige til injektion
US6900184B2 (en) 2003-04-14 2005-05-31 Wyeth Holdings Corporation Compositions containing pipercillin and tazobactam useful for injection

Also Published As

Publication number Publication date
PL1468697T3 (pl) 2008-05-30
NZ543005A (en) 2009-03-31
CH695185A9 (fr) 2006-02-28
KR100824554B1 (ko) 2008-04-24
US7498312B2 (en) 2009-03-03
FR2853547A1 (fr) 2004-10-15
AR043863A1 (es) 2005-08-17
SA04250119B1 (ar) 2008-03-30
TWI308069B (en) 2009-04-01
MXPA05010996A (es) 2005-12-12
ECSP056100A (es) 2006-03-01
JP4644659B2 (ja) 2011-03-02
CO5700796A2 (es) 2006-11-30
DK1468697T3 (da) 2008-04-14
CL2004000782A1 (es) 2005-03-04
BRPI0409450A (pt) 2006-05-02
ATE381947T1 (de) 2008-01-15
RU2007142454A (ru) 2009-05-27
BRPI0409450B1 (pt) 2016-07-12
CH695185A5 (fr) 2006-01-13
CY1108064T1 (el) 2014-02-12
CA2464258A1 (en) 2004-10-14
DE602004010862D1 (de) 2008-02-07
SI1468697T1 (sl) 2008-04-30
CN1802179B (zh) 2011-09-14
DE602004010862T2 (de) 2009-01-02
US8133883B2 (en) 2012-03-13
US20060234995A1 (en) 2006-10-19
US7915229B2 (en) 2011-03-29
IL171337A (en) 2011-03-31
GB2400557A (en) 2004-10-20
ZA200508315B (en) 2008-04-30
CA2464258C (en) 2005-06-07
FR2853547B1 (fr) 2006-08-04
CN1802179A (zh) 2006-07-12
TW200503758A (en) 2005-02-01
MY139099A (en) 2009-08-28
KR20060014375A (ko) 2006-02-15
PT1468697E (pt) 2008-03-05
NO20054789L (no) 2005-12-13
BRPI0409450B8 (pt) 2021-05-25
EP1468697B1 (en) 2007-12-26
GB2400557B (en) 2005-06-15
NO20054789D0 (no) 2005-10-18
RU2005135135A (ru) 2006-06-10
US20090176720A1 (en) 2009-07-09
WO2004091666A8 (en) 2005-11-10
WO2004091666A1 (en) 2004-10-28
US20110166091A1 (en) 2011-07-07
AU2004229407A1 (en) 2004-10-28
AU2004229407B2 (en) 2010-04-22
JP2006523695A (ja) 2006-10-19
ES2298672T3 (es) 2008-05-16
HK1069775A1 (en) 2005-06-03
EP1468697A1 (en) 2004-10-20
CR8035A (es) 2006-05-30
GB0407853D0 (en) 2004-05-12
RU2322980C2 (ru) 2008-04-27

Similar Documents

Publication Publication Date Title
CR9792A (es) Composiciones que contienen piperacilina y tazobactam utiles para inyecciones (divisional de exp. 8035)
BRPI0414711A (pt) processo para a desoxidação de superfìcies metálicas, e, composições aquosa, ácida para a desoxidação de superfìcies metálicas
AR021049A1 (es) Una composicion detergente solida
BRPI0408382A (pt) composição contendo materiais de zinco particulado que têm um tamanho definido de cristalito
AR007536A1 (es) Una composicion de escamas de aditivo para distribuir un agente de beneficio, un procedimiento para formarla, una composicion de barra detocador moldeada por extrusion que la comprende, y un metodo de aumento de la deposicion del agente de beneficio desde una composicion de barra.
BR9917282A (pt) Composição oral para inibição de mal odor oral
PA8587301A1 (es) Composiciones para remover manchas de superficies dentales y metodos de fabricacion y uso de ellas
CO5600989A2 (es) Composiciones de chicle y confitura con composiciones de agente removedor de manchas encapsuladas y metodos de fabricacion y uso de las mismas
AR007324A1 (es) Una composicion lubricante concentrada, un lubricante que la comprende y un metodo para lubricar un equipo transportador mediante dicha composicion
AR034210A1 (es) Aditivo de secado para lechada cementicia, lechada cementicia y metodo para reducir los requerimientos de agua de dicha lechada
BR0214496A (pt) Métodos e composições a base de peroxigênio para limpeza ou sanitização de tapete ou estofamento
BR0215898A (pt) Composição e método para a formação não permanente durável de pelo menos uma fibra queratìnica ou para a retenção durável de uma forma não permanente de pelo menos uma fibra queratìnica e kit para proteger pelo menos uma fibra queratìnica contra danos extrìnsecos
BR9812848A (pt) Composições contendo alvejante de peroxigênio compreendendo um sistema de agente de quelação em particular
AR034898A1 (es) Composicion cristalina que contiene escitalopram
WO2001091738A3 (en) Naaladase inhibitors for treating amyotrophic lateral sclerosis
EA200401434A1 (ru) Обработка опасного, являющегося отходом, материала
ATE475631T1 (de) Partikel eines geschmolzenen keramikmaterials
ES2134936T3 (es) Alquil-glicosido, su uso para fines de limpieza, y composicion de limpieza.
MX170928B (es) Composicion limpiadora para superficies duras
ATE245028T1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
DK1274883T3 (da) Korrosionsinhibitor
CR7515A (es) Composicion veterinaria inyectable para animales pequenos
AR044449A1 (es) Composiciones acuosas desinfectantes y/o bactericidas
ES2123830T3 (es) Metodo para limpiar superficies de vinilo mediante composiciones ligeramente acidas para limpiar superficies duras que contienen tensioactivos detergentes de oxido de amina.
NO20013499D0 (no) Farmasöytisk blanding omfattende en kombinasjon av en profen og andre aktive forbindelser

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)